Neuronetics (STIM) Earnings Analysis
Neuronetics (STIM) has no confirmed upcoming earnings date. Last quarter (2026-03-17) it beat with EPS -0.1 USD vs -0.12 USD est (+16.7%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -3.57.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does STIM next report earnings?
No confirmed upcoming earnings date is currently scheduled for STIM. This page updates as the calendar is published.
STIM earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-17 | -0.1 USD | -0.12 USD | +16.7% | Beat |
| 2025-03-04 | -0.33 USD | -0.26 USD | -26.9% | Miss |
| 2024-08-12 | -0.33 USD | -0.27 USD | -22.2% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
STIM valuation and analyst view
| Trailing P/E | -3.57 |
|---|---|
| Trailing EPS | -0.53332 USD |
| Price / book | 10.12 |
| Dividend yield | 0.00% |
| Market cap | 0.13B |
| Analyst consensus | Buy (5 buy / 2 hold / 0 sell) |
| Avg price target | 5 USD |
Related research pages
Frequently asked questions
When is Neuronetics (STIM)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for STIM. This page updates as the calendar is published.
Did STIM beat earnings last quarter?
In its 2026-03-17 report, STIM posted EPS of -0.1 USD versus a -0.12 USD estimate — a beat of 16.7%.
What is STIM's earnings track record?
Over the last 3 reported quarters with consensus data, STIM beat estimates 1 times (33%).
What is STIM's current P/E ratio and EPS?
STIM trades at a trailing P/E of -3.57 on trailing EPS of -0.5333170472344767 USD.
What do analysts rate STIM?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 5 USD.